LINC00852 and prostate carcinoma: Furthermore, we confirmed that overexpression of LINC00852 promoted the proliferation, migration and invasion of prostate cancer cells, and knocking-down of LINC00852 could inhibited the progression of prostate cancer cell, suggesting that LINC00852 played a cancer-promoting effect in prostate cancer, these results were consistent with the report of Yi et al. [8].